Literature DB >> 2726753

Role of early region 3 (E3) in pathogenesis of adenovirus disease.

H S Ginsberg1, U Lundholm-Beauchamp, R L Horswood, B Pernis, W S Wold, R M Chanock, G A Prince.   

Abstract

The cotton rat Sigmodon hispidus has provided an animal model of adenovirus pneumonia that permits investigation of the viral gene products required to produce the disease and the molecular mechanisms effecting the damage. This study was carried out to test the hypothesis that early region 3 (E3) of the adenovirus genome plays a critical role in pathogenesis of the virus's disease process even though none of its gene products are essential for its replication. Mutants whose E3 region is largely deleted (i.e., H2dl801 and H5dl327) replicated like wild-type virus in the cotton rats' lungs, but the lymphocyte and macrophage/monocyte inflammatory response was markedly increased. Viruses containing mutations that ablated production of the 19-kDa glycoprotein had the same effect as H2dl801 and H5dl327. However, mutants with deletions in the other E3 open reading frames, some of which encode known proteins, did not differ from wild-type virus in their pathogenic properties. The 19-kDa glycoprotein markedly reduces expression of the class I major histocompatibility complex antigens on the surface of infected cells. A complete correlation was found between those mutants that had increased pathogenic effects and those that lost the ability to reduce transport of the class I major histocompatibility complex antigens to surface of infected cells (i.e., all mutants unable to express the 19-kDa glycoprotein). H5sub304, which has a deletion between 83.2 and 85.1 map units in the E3B region and expresses the 19-kDa glycoprotein, did not increase the extent of pneumonia but qualitatively changed the inflammatory response in that increased numbers of polymorphonuclear leukocytes accumulated, often in small foci.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726753      PMCID: PMC287233          DOI: 10.1073/pnas.86.10.3823

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Identification and classification of adenoviruses.

Authors:  H S GINSBERG
Journal:  Virology       Date:  1962-10       Impact factor: 3.616

2.  Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.

Authors:  W P Edmondson; R H Purcell; B F Gundelfinger; J W Love; W Ludwig; R M Chanock
Journal:  JAMA       Date:  1966-02-07       Impact factor: 56.272

3.  The genomic map position of the adenovirus type 2 glycoprotein.

Authors:  S Ross; A J Levine
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

4.  Isolation of deletion and substitution mutants of adenovirus type 5.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

5.  Synthesis and genomic site for an adenovirus type 2 early glycoprotein.

Authors:  H Persson; M Jansson; L Philipson
Journal:  J Mol Biol       Date:  1980-02-05       Impact factor: 5.469

6.  Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

Authors:  S S Challberg; G Ketner
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

7.  Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus.

Authors:  M J Ensinger; H S Ginsberg
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

8.  Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses.

Authors:  M Green; W S Wold; J K Mackey; P Rigden
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

9.  Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.

Authors:  T J Kelly; A M Lewis
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

10.  Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.

Authors:  F H Top; R A Grossman; P J Bartelloni; H E Segal; B A Dudding; P K Russell; E L Buescher
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

View more
  95 in total

Review 1.  The promise and potential hazards of adenovirus gene therapy.

Authors:  L S Young; V Mautner
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

3.  Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules.

Authors:  P Flomenberg; J Szmulewicz; E Gutierrez; H Lupatkin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Open reading frame E3-10.9K of subspecies B1 human adenoviruses encodes a family of late orthologous proteins that vary in their predicted structural features and subcellular localization.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

5.  The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.

Authors:  A Lieber; C Y He; L Meuse; D Schowalter; I Kirillova; B Winther; M A Kay
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.

Authors:  J T Bruder; T Jie; D L McVey; I Kovesdi
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5.

Authors:  C Caravokyri; K N Leppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Discovery of small molecule inhibitors of adenovirus by disrupting E3-19K/HLA-A2 interactions.

Authors:  Jinhong Ren; Nikita R Dsouza; Hui Deng; Hyun Lee; Marlene Bouvier; Michael E Johnson
Journal:  Bioorg Med Chem Lett       Date:  2018-07-29       Impact factor: 2.823

9.  A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.

Authors:  H S Ginsberg; L L Moldawer; P B Sehgal; M Redington; P L Kilian; R M Chanock; G A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

10.  The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization.

Authors:  A Elsing; H G Burgert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.